Adam Crystal

CIK: 0001825445

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)20 (64.5%)

Position reduction

Option Exercises (M)9 (29.0%)

Derivative conversions

Awards (A)2 (6.5%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

TNGX

Tango Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (31 total)

TNGX
Tango Therapeutics, Inc.
Oct 1, 2026
Sale(S)
Direct
26.4K shares at avg. $24.45$646K
TNGX
Tango Therapeutics, Inc.
Oct 1, 2026
Exercise(M)
Direct
27K shares at avg. $5.20$140K
TNGX
Tango Therapeutics, Inc.
Oct 1, 2026
Sale(S)
Direct
600 shares at avg. $25.32$15K
TNGX
Tango Therapeutics, Inc.
Sep 1, 2026
Sale(S)
Direct
27K shares at avg. $22.37$604K
TNGX
Tango Therapeutics, Inc.
Sep 1, 2026
Exercise(M)
Direct
27K shares at avg. $5.20$140K
TNGX
Tango Therapeutics, Inc.
Aug 3, 2026
Sale(S)
Direct
21.7K shares at avg. $27.35$594K
TNGX
Tango Therapeutics, Inc.
Aug 3, 2026
Sale(S)
Direct
5.3K shares at avg. $26.79$141K
TNGX
Tango Therapeutics, Inc.
Aug 3, 2026
Exercise(M)
Direct
27K shares at avg. $5.20$140K
TNGX
Tango Therapeutics, Inc.
Jul 1, 2026
Sale(S)
Direct
7.4K shares at avg. $30.25$223K
TNGX
Tango Therapeutics, Inc.
Jul 1, 2026
Sale(S)
Direct
19.6K shares at avg. $29.34$576K
TNGX
Tango Therapeutics, Inc.
Jul 1, 2026
Exercise(M)
Direct
27K shares at avg. $5.20$140K
TNGX
Tango Therapeutics, Inc.
Jun 1, 2026
Sale(S)
Direct
20.9K shares at avg. $23.06$481K
TNGX
Tango Therapeutics, Inc.
Jun 1, 2026
Sale(S)
Direct
6.1K shares at avg. $22.25$137K
TNGX
Tango Therapeutics, Inc.
Jun 1, 2026
Exercise(M)
Direct
27K shares at avg. $5.20$140K
TNGX
Tango Therapeutics, Inc.
May 1, 2026
Sale(S)
Direct
25.9K shares at avg. $21.19$549K
TNGX
Tango Therapeutics, Inc.
May 1, 2026
Exercise(M)
Direct
27K shares at avg. $5.20$140K
TNGX
Tango Therapeutics, Inc.
May 1, 2026
Sale(S)
Direct
1.1K shares at avg. $22.00$24K
TNGX
Tango Therapeutics, Inc.
Apr 15, 2026
Exercise(M)
Direct
38.5K shares at avg. $5.20$200K
TNGX
Tango Therapeutics, Inc.
Apr 15, 2026
Sale(S)
Direct
38.5K shares at avg. $25.00$962K
TNGX
Tango Therapeutics, Inc.
Apr 1, 2026
Sale(S)
Direct
27K shares at avg. $21.20$572K
TNGX
Tango Therapeutics, Inc.
Apr 1, 2026
Exercise(M)
Direct
27K shares at avg. $5.20$140K
TNGX
Tango Therapeutics, Inc.
Mar 25, 2026
Sale(S)
Direct
12K shares at avg. $20.11$241K
TNGX
Tango Therapeutics, Inc.
Mar 25, 2026
Exercise(M)
Direct
12K shares at avg. $5.20$62K
TNGX
Tango Therapeutics, Inc.
Mar 5, 2026
Sale(S)
Direct
20.3K shares at avg. $15.00$304K
TNGX
Tango Therapeutics, Inc.
Feb 25, 2026
Sale(S)
Direct
54.3K shares at avg. $12.77$694K

		Type	Shares	Price		Ownership
Oct 1, 2026	TNGX Tango Therapeutics, Inc.	Sale(S)	26,400	$24.45	$645,604	Direct
Oct 1, 2026	TNGX Tango Therapeutics, Inc.	Exercise(M)	27,000	$5.20	$140,400	Direct
Oct 1, 2026	TNGX Tango Therapeutics, Inc.	Sale(S)	600	$25.32	$15,192	Direct
Sep 1, 2026	TNGX Tango Therapeutics, Inc.	Sale(S)	27,000	$22.37	$603,909	Direct
Sep 1, 2026	TNGX Tango Therapeutics, Inc.	Exercise(M)	27,000	$5.20	$140,400	Direct
Aug 3, 2026	TNGX Tango Therapeutics, Inc.	Sale(S)	21,733	$27.35	$594,417	Direct
Aug 3, 2026	TNGX Tango Therapeutics, Inc.	Sale(S)	5,267	$26.79	$141,100	Direct
Aug 3, 2026	TNGX Tango Therapeutics, Inc.	Exercise(M)	27,000	$5.20	$140,400	Direct
Jul 1, 2026	TNGX Tango Therapeutics, Inc.	Sale(S)	7,371	$30.25	$222,946	Direct
Jul 1, 2026	TNGX Tango Therapeutics, Inc.	Sale(S)	19,629	$29.34	$575,962	Direct
Jul 1, 2026	TNGX Tango Therapeutics, Inc.	Exercise(M)	27,000	$5.20	$140,400	Direct
Jun 1, 2026	TNGX Tango Therapeutics, Inc.	Sale(S)	20,860	$23.06	$480,944	Direct
Jun 1, 2026	TNGX Tango Therapeutics, Inc.	Sale(S)	6,140	$22.25	$136,627	Direct
Jun 1, 2026	TNGX Tango Therapeutics, Inc.	Exercise(M)	27,000	$5.20	$140,400	Direct
May 1, 2026	TNGX Tango Therapeutics, Inc.	Sale(S)	25,900	$21.19	$548,901	Direct
May 1, 2026	TNGX Tango Therapeutics, Inc.	Exercise(M)	27,000	$5.20	$140,400	Direct
May 1, 2026	TNGX Tango Therapeutics, Inc.	Sale(S)	1,100	$22.00	$24,196	Direct
Apr 15, 2026	TNGX Tango Therapeutics, Inc.	Exercise(M)	38,460	$5.20	$199,992	Direct
Apr 15, 2026	TNGX Tango Therapeutics, Inc.	Sale(S)	38,460	$25.00	$961,500	Direct
Apr 1, 2026	TNGX Tango Therapeutics, Inc.	Sale(S)	27,000	$21.20	$572,478	Direct
Apr 1, 2026	TNGX Tango Therapeutics, Inc.	Exercise(M)	27,000	$5.20	$140,400	Direct
Mar 25, 2026	TNGX Tango Therapeutics, Inc.	Sale(S)	12,000	$20.11	$241,320	Direct
Mar 25, 2026	TNGX Tango Therapeutics, Inc.	Exercise(M)	12,000	$5.20	$62,400	Direct
Mar 5, 2026	TNGX Tango Therapeutics, Inc.	Sale(S)	20,251	$15.00	$303,765	Direct
Feb 25, 2026	TNGX Tango Therapeutics, Inc.	Sale(S)	54,345	$12.77	$694,208	Direct

1-25 of 31 transactions

About Crystal Adam

Crystal Adam (SEC CIK 0001825445) files insider reports with the SEC as President, R&D of Tango Therapeutics, Inc. (TNGX).

Signal8 holds 14 ownership filings by Crystal Adam, all Form 4s, filed between Feb 5, 2025 and Oct 5, 2026. Those filings report 31 transactions, from Feb 3, 2025 to Oct 1, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Crystal Adam's filings is in BOSTON, MA.

Recent filings by Crystal Adam

Oct 1, 2026: Open-market sale of TNGX shares (Form 4, code S).
Oct 1, 2026: Option exercise of TNGX shares (Form 4, code M).
Oct 1, 2026: Open-market sale of TNGX shares (Form 4, code S).
Sep 1, 2026: Open-market sale of TNGX shares (Form 4, code S).
Sep 1, 2026: Option exercise of TNGX shares (Form 4, code M).

Other insiders filing for Tango Therapeutics, Inc. (TNGX)

Newcomb Jessica, Principal Accounting Officer
Azelby Robert, Director
Ketchum John B, Director
Calhoun Lesley Ann, Director
Rothenberg Mace, Director
Lee Sung, Director

How to read Form 4 transaction codes